Humoral Immune Response to COVID-19 Vaccination in Hemodialysis Patients: A Retrospective, Observational Case-Control Pilot Study
- PMID: 34978702
- PMCID: PMC8721477
- DOI: 10.1007/s40292-021-00502-5
Humoral Immune Response to COVID-19 Vaccination in Hemodialysis Patients: A Retrospective, Observational Case-Control Pilot Study
Abstract
Introduction: Coronavirus 2 disease is associated with increased mortality and morbidity in chronic hemodialysis patients METHODS: A retrospective, observational case-control pilot study was conducted on consecutive hemodialysis outpatients (cases) and control group of individuals with preserved renal function. Complete SARS-CoV-2 vaccination with BNT162b2 mRNA vaccine, followed by determination of serum antibodies after the second dose, were required from participants in both groups. Previous COVID-19 was an exclusion criterium.
Results: 21 hemodialysis patients (M:F = 13:8, mean age 67.5 ± 13.4) and 16 controls without chronic kidney disease (M:F = 4:12, mean age 46.8 ± 12.7) were included. Hemodialysis patients had lower mean titers of serum antibodies to the SARS-CoV-2 spike antigen compared with controls (492.39 vs 1901.20 IU/mL, respectively; p < 0.001), a finding that was confirmed in the age-matched analysis on 18 participants (580.8 vs 1836.4 IU/mL, p = 0.006).
Conclusions: This study supports the finding of hyporesponsiveness to mRNA vaccination among hemodialysis patients.
Keywords: Antibody activity; COVID-19; Hemodialysis; mRNA vaccines.
© 2021. Italian Society of Hypertension.
Conflict of interest statement
All the authors declare no conflict of interest
Figures
Comment in
-
COVID-19 Vaccination in Hemodialysis Patients Correspondence.High Blood Press Cardiovasc Prev. 2022 May;29(3):311. doi: 10.1007/s40292-022-00510-z. Epub 2022 Mar 8. High Blood Press Cardiovasc Prev. 2022. PMID: 35258795 Free PMC article. No abstract available.
References
-
- Razzaghi H, Wang Y, Lu H, Marshall KE, Dowling NF, Paz-Bailey G, Twentyman ER, Peacock G, Greenlund KJ. Estimated county-level prevalence of selected underlying medical conditions associated with increased risk for severe COVID-19 illness—United States, 2018. MMWR Morb Mortal Wkly Rep. 2020;69(29):945–950. doi: 10.15585/mmwr.mm6929a1. - DOI - PMC - PubMed
-
- Jager KJ, Kramer A, Chesnaye NC, Couchoud C, Sánchez-Álvarez JE, Garneata L, Collart F, Hemmelder MH, Ambühl P, Kerschbaum J, Legeai C, Del Pino Y, Pino MD, Mircescu G, Mazzoleni L, Hoekstra T, Winzeler R, Mayer G, Stel VS, Wanner C, Zoccali C, Massy ZA. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int. 2020;98(6):1540–1548. doi: 10.1016/j.kint.2020.09.006. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
